Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 0 | 0 | 0 | 4,015 |
| Gross Profit | N/A | N/A | N/A | N/A | 4,015 |
| Operating Expenses | 78,135 | 59,331 | 72,861 | 60,138 | 50,493 |
| Operating Income | -78,135 | -59,331 | -72,861 | -60,138 | -46,478 |
| Other Income | 5,008 | 5,492 | 2,961 | 2,681 | 3,081 |
| Pre-tax Income | -73,127 | -53,839 | -69,900 | -57,457 | -43,397 |
| Net Income Continuous | -73,127 | -53,839 | -69,900 | -57,457 | -43,397 |
| Net Income | $-73,127 | $-53,839 | $-69,900 | $-57,457 | $-43,397 |
| EPS Basic Total Ops | -0.65 | -0.48 | -0.76 | -0.65 | -0.50 |
| EPS Basic Continuous Ops | -0.65 | -0.48 | -0.76 | -0.65 | -0.50 |
| EPS Diluted Total Ops | -0.65 | -0.48 | -0.76 | -0.65 | -0.50 |
| EPS Diluted Continuous Ops | -0.65 | -0.48 | -0.76 | -0.65 | -0.50 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.48 | -0.75 | -0.65 | -0.50 |
| EBITDA(a) | $-77,420 | $-58,578 | $-72,085 | $-60,221 | $-46,963 |